| scholarly article | Q13442814 |
| P50 | author | Jonathan R Lindner | Q89706631 |
| Alexander Klibanov | Q4719325 | ||
| P2093 | author name string | Ley K | |
| Song J | |||
| Christiansen J | |||
| Xu F | |||
| P4510 | describes a project that uses | microbubble | Q6839290 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| microbubble | Q6839290 | ||
| P304 | page(s) | 2107-2112 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin | |
| P478 | volume | 104 |
| Q27304629 | A Targeting Microbubble for Ultrasound Molecular Imaging |
| Q38005672 | A molecular imaging primer: modalities, imaging agents, and applications |
| Q30491503 | A stimulus-responsive contrast agent for ultrasound molecular imaging |
| Q35118263 | A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature |
| Q30427317 | Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents |
| Q47979877 | Acoustic characterization of a new trisacryl contrast agent. Part I: In vitro study |
| Q30475340 | Advances in molecular imaging with ultrasound |
| Q89231717 | An Introduction to Contrast-Enhanced Ultrasound for Nephrologists |
| Q37626229 | An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide |
| Q28260061 | An in vivo validation of the application of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d ultrasound |
| Q30430108 | Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles |
| Q38218986 | Antibody-based imaging strategies for cancer. |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q30277713 | Assessment of ischaemia-reperfusion injury in the mice testis by using contrast ultrasound molecular imaging |
| Q30408549 | Binding dynamics of targeted microbubbles in response to modulated acoustic radiation force |
| Q30375867 | Blinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging. |
| Q51090985 | Characterization of the in vitro adherence behavior of ultrasound responsive double-shelled microspheres targeted to cellular adhesion molecules. |
| Q40197691 | Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes |
| Q51152653 | Comparison of Magnetic Microbubbles and Dual-modified Microbubbles Targeted to P-selectin for Imaging of Acute Endothelial Inflammation in the Abdominal Aorta. |
| Q30437048 | Contrast ultrasound assessment of angiogenesis by perfusion and molecular imaging |
| Q37385650 | Contrast ultrasound molecular imaging of inflammation in cardiovascular disease |
| Q57460608 | Contrast-enhanced ultrasound of the abdominal aorta - current status and future perspectives |
| Q37657893 | Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries |
| Q30435874 | Current status and prospects for microbubbles in ultrasound theranostics |
| Q39622089 | Design and characterization of targeted ultrasound microbubbles for diagnostic use. |
| Q30559110 | Detection of antecedent myocardial ischemia with multiselectin molecular imaging |
| Q30310273 | Detection of inflamed plaques with contrast ultrasound |
| Q50995366 | Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. |
| Q37992560 | Development and application of endothelium-targeted microparticles for molecular magnetic resonance imaging |
| Q92396758 | Development of a Translatable Ultrasound Molecular Imaging Agent for Inflammation |
| Q84329824 | Development of antibody-carrying microbubbles based on clinically available ultrasound contrast agent for targeted molecular imaging: a preliminary chemical study |
| Q37838232 | Diagnostic and therapeutic strategies for small abdominal aortic aneurysms |
| Q30434058 | Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels |
| Q30433916 | Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow |
| Q30461411 | Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus |
| Q30477838 | Effect of acoustic power on in vivo molecular imaging with targeted microbubbles: implications for low-mechanical index real-time imaging. |
| Q36190734 | Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats |
| Q35930068 | Endothelial targeting of antibody-decorated polymeric filomicelles |
| Q30443456 | Enhanced targeting of ultrasound contrast agents using acoustic radiation force |
| Q30384012 | Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1. |
| Q53640913 | Evaluation of the specific adsorption of biotinylated microbubbles using a quartz crystal microbalance. |
| Q30310252 | Evolving applications for contrast ultrasound |
| Q30442068 | Factors affecting the endothelial retention of targeted microbubbles: influence of microbubble shell design and cell surface projection of the endothelial target molecule. |
| Q30469164 | Focused ultrasound surgery in oncology: overview and principles |
| Q30411283 | Galactosylated poly-L-lysine targeted microbubbles for ultrasound mediated antisense c-myc gene transfection in hepatocellular carcinoma cells |
| Q30402584 | Grey scale enhancement of rabbit liver and kidney by intravenous injection of a new lipid-coated ultrasound contrast agent |
| Q94662320 | High-Resolution Imaging of Intracellular Calcium Fluctuations Caused by Oscillating Microbubbles |
| Q26764836 | Imaging Atherosclerosis |
| Q35262701 | Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent |
| Q30464469 | Imaging myocardial metabolic remodeling |
| Q38827418 | Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization. |
| Q30364918 | In vitro methods to study bubble-cell interactions: Fundamentals and therapeutic applications |
| Q24804921 | In vivo imaging approaches in animal models of rheumatoid arthritis |
| Q37837837 | In vivo small animal imaging: current status and future prospects |
| Q30310913 | Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin |
| Q30362133 | Intravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force. |
| Q53482251 | Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force. |
| Q34588850 | Investigation into the impact of diagnostic ultrasound with microbubbles on the capillary permeability of rat hepatomas |
| Q38858230 | Investigation of polymer-shelled microbubble motions in acoustophoresis. |
| Q30407883 | Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression |
| Q84791739 | Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1 |
| Q30476296 | Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics |
| Q57185167 | MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis |
| Q50115112 | Manufacture and acoustical characterisation of a high-frequency contrast agent for targeting applications |
| Q30425612 | Micro-ultrasound for preclinical imaging |
| Q51031499 | Microbubble Enzyme-Linked Immunosorbent Assay for the Detection of Targeted Microbubbles in in Vitro Static Binding Assays. |
| Q90346534 | Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications |
| Q30433669 | Microbubbles in medical imaging: current applications and future directions |
| Q30418235 | Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow |
| Q30465343 | Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q27339951 | Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis |
| Q90667459 | Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow |
| Q30386860 | Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury. |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q51621744 | Molecular evaluation of thrombosis using X-ray phase contrast imaging with microbubbles targeted to P-selectin in mice. |
| Q30484224 | Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation |
| Q30461248 | Molecular imaging of cardiovascular disease using ultrasound |
| Q37511734 | Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography |
| Q30457844 | Molecular imaging of disease with targeted contrast ultrasound imaging |
| Q30489494 | Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q30492960 | Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease |
| Q30443135 | Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia |
| Q37752025 | Molecular imaging with contrast enhanced ultrasound |
| Q30312262 | Molecular imaging with contrast ultrasound and targeted microbubbles |
| Q83669147 | Molecular imaging with targeted contrast ultrasound |
| Q30474579 | Molecular imaging: current status and emerging strategies |
| Q37777365 | Molecular ultrasound imaging and its potential for paediatric radiology |
| Q36297117 | Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy |
| Q30474725 | Molecular ultrasound imaging: current status and future directions |
| Q35936423 | Molecular, cellular and functional imaging of atherothrombosis |
| Q42370846 | Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging. |
| Q55416268 | Multimodal Molecular Imaging: Current Status and Future Directions. |
| Q31005913 | NIR spectroscopic detection of breast cancer |
| Q47661806 | New Ultrasound Techniques Promise Further Advances in AKI and CKD. |
| Q30455730 | Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis |
| Q30279077 | Optical Verification of Microbubble Response to Acoustic Radiation Force in Large Vessels With In Vivo Results |
| Q39411412 | Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength |
| Q41131686 | PBCA-based polymeric microbubbles for molecular imaging and drug delivery |
| Q30440315 | Polyglycerolsulfate functionalized gold nanorods as optoacoustic signal nanoamplifiers for in vivo bioimaging of rheumatoid arthritis. |
| Q36076342 | Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties |
| Q30448551 | Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging |
| Q30383852 | Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers. |
| Q35629916 | Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. |
| Q38764386 | Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies |
| Q50903873 | Quantitative ultrasound molecular imaging. |
| Q30417617 | Real-time targeted molecular imaging using singular value spectra properties to isolate the adherent microbubble signal |
| Q39334943 | Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations |
| Q35643425 | Recent trends in antibody-based oncologic imaging |
| Q57154180 | SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q53132563 | Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent. |
| Q30411087 | Shear forces from flow are responsible for a distinct statistical signature of adherent microbubbles in large vessels. |
| Q38362389 | Stabilization and fabrication of microbubbles: applications for medical purposes and functional materials |
| Q36297281 | Sulfonated Polyethylenimine for Photosensitizer Conjugation and Targeting |
| Q51053056 | Superhydrophobic silica nanoparticles as ultrasound contrast agents. |
| Q38445821 | Synthesis of laboratory Ultrasound Contrast Agents. |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q30475849 | Targeted delivery of therapeutics to endothelium |
| Q38598987 | Targeted endothelial nanomedicine for common acute pathological conditions |
| Q30734358 | Targeted imaging using ultrasound |
| Q38029695 | Targeted interception of signaling reactive oxygen species in the vascular endothelium |
| Q35098774 | Targeted modulation of reactive oxygen species in the vascular endothelium |
| Q38056019 | Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents |
| Q30472688 | Targeted renal therapies through microbubbles and ultrasound☆ |
| Q30442452 | Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow |
| Q38364441 | Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy |
| Q48810713 | Targeted ultrasound contrast imaging of matrix metalloproteinase-2 in ischemia-reperfusion rat model: ex vivo and in vivo studies |
| Q34935960 | Targeting antioxidant and antithrombotic biotherapeutics to endothelium |
| Q47234214 | Targeting of microbubbles: contrast agents for ultrasound molecular imaging. |
| Q47250590 | Targeting therapeutics to endothelium: are we there yet? |
| Q30276184 | The Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging |
| Q36945842 | The application of microbubbles for targeted drug delivery |
| Q45339905 | The effect of binding on the subharmonic emissions from individual lipid-encapsulated microbubbles at transmit frequencies of 11 and 25 MHz. |
| Q47675852 | The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series). |
| Q28182332 | The role of selectins in inflammation and disease |
| Q35968117 | The role of ultrasound in molecular imaging |
| Q24804233 | The use of microbubbles to target drug delivery |
| Q30431243 | US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice |
| Q30275871 | Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See? |
| Q30455981 | Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies |
| Q36077557 | Ultrasonographic contrast media: has the time come in obstetrics and gynecology? |
| Q30252540 | Ultrasound Molecular Imaging of Inflammation in Mouse Abdominal Aorta |
| Q36160656 | Ultrasound contrast agents for brain perfusion imaging and ischemic stroke therapy |
| Q26853667 | Ultrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imaging |
| Q30482585 | Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering |
| Q24791766 | Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary atherosclerotic plaque |
| Q30278971 | Ultrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy |
| Q53286813 | Ultrasound inflammation imaging in rats with myocardial ischemia-reperfusion: evaluation by non-specific targeted contrast microbubbles. |
| Q37424337 | Ultrasound molecular imaging |
| Q37506868 | Ultrasound molecular imaging of atherosclerosis |
| Q30434285 | Ultrasound molecular imaging of cardiovascular disease |
| Q30432690 | Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. |
| Q30445036 | Ultrasound molecular imaging with targeted microbubble contrast agents |
| Q89706634 | Ultrasound molecular imaging: insights into cardiovascular pathology |
| Q42314914 | Ultrasound to assess diaphragmatic function in the critically ill-a critical perspective |
| Q30303105 | Ultrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study |
| Q36640312 | Ultrasound-induced cavitation: applications in drug and gene delivery |
| Q30416117 | Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles |
| Q58775112 | Use of cationic microbubbles targeted to P-selectin to improve ultrasound-mediated gene transfection of hVEGF to the ischemic myocardium |
| Q51762401 | Use of intravital microscopy to study the microvascular behavior of microbubble-based ultrasound contrast agents. |
| Q30447632 | Use of ultrasound to assess renal reperfusion and P-selectin expression following unilateral renal ischemia |
| Q53258247 | Utility of contrast-enhanced ultrasonography for qualitative imaging of atherosclerosis in Watanabe heritable hyperlipidemic rabbits: initial experimental study |
| Q92944443 | Validation of Normalized Singular Spectrum Area as a Classifier for Molecularly Targeted Microbubble Adherence |
| Q27026630 | Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm |
| Q41510549 | Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model |
| Q79449729 | [Advances in cardiovascular medicine through molecular imaging] |
| Q50749482 | [Evaluation of renal tissue ischemia-reperfusion injury with ultrasound radiation force and targeted microbubbles]. |
| Q53472185 | [Molecular imaging of tumor blood vessels]. |
| Q81778491 | [Possible target specific molecular imaging with ultrasound contrast agents] |
| Q30425448 | scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis |
Search more.